HFSA's 21st Annual Scientific Meeting

JOINT SESSION (AHA)– What Can You Do To Prevent HF?

Sep 16, 2017 2:30pm ‐ Sep 16, 2017 4:00pm

Credits: None available.


Thus, there is an unmet need for new inotropic strategies. This session will review the clinical need for new inotropic strategies, the basic science underpinning novel strategies for enhancing cardiac contractility, and emerging date from proof-of-concept pre-clinical clinical research. Target audience is primarily physician and non-physician practitioners who care for patients with severe or unstable heart failure syndromes. Additionally, this session will be of value for clinical trainees and scientists involved with early and late therapeutic drug development.


  • Mark Drazner, MD, MSc, Clinical Chief of Cardiology, UT Southwestern Medical Center, Dallas, TX
  • Nancy Albert, RN, PhD. FHFSA, Cleveland Clinic


Credits: None available.

You must be logged in and own this session in order to post comments.